THC-Dominant Cannabis and PTSD: What a New UK Study Found

Real-world data on inhaled cannabis for post-traumatic stress disorder.

A recent UK study explored how controlled inhalation of THC-dominant cannabis flower affects people living with post-traumatic stress disorder (PTSD). PTSD is a mental health condition estimated to affect about 4% of the UK population. A diagnosis involves symptoms across four areas: intrusive memories, avoidance behaviors, altered mood, and altered reactivity. Researchers set out to see whether THC — a key compound in cannabis — could help manage these symptoms in everyday clinical practice.

The study drew on data from the UK's T21 patient registry, which collects health information from patients prescribed medical cannabis. To be included, participants needed a confirmed PTSD diagnosis, completed health questionnaires before and after starting treatment, and a prescription for a THC-dominant cannabis flower.

What the Study Found

The study involved 58 participants — most of them men, with an average age of around 39, and the large majority had used cannabis before. They completed health surveys at the start of treatment, at three months, and again at six months.

By the three-month mark, participants reported significant improvements in overall health, mood, and sleep quality. One measure used as a proxy for health-related quality of life improved too, but did not quite reach statistical significance — an honest detail worth noting. Crucially, the improvements weren't just a short-term bump: they were sustained, and for some participants grew further, by the six-month check-in. Participants reported fewer intrusive memories, better control over mood, and reduced reactivity. Over the six months, PTSD symptom severity declined meaningfully, and no side effects were reported.

Important Context

These are encouraging results, but a few points matter for interpreting them. This was an observational, real-world study rather than a randomized controlled trial — it can show an association between treatment and improvement, but not prove cause and effect. The participants were also almost all cannabis-experienced, and the researchers specifically highlight the need for more research on people who are new to cannabis, where the picture may differ. It's also worth noting that the study's authors are affiliated with commercial medical cannabis organizations.

Even so, the findings add to a meaningful body of evidence. Since 2018, doctors in the UK have been able to prescribe medical cannabis to patients who haven't responded well to standard treatments. Other analyses from UK cannabis registries have similarly reported benefits for chronic pain, anxiety, and depression. For people with PTSD who have struggled to find relief through conventional medication, studies like this one point to an option worth discussing with a knowledgeable clinician — as part of properly supervised care.

Reference: Sultan W, Madiedo A, Moreno-Sanz G. Controlled Inhalation of Tetrahydrocannabinol-Predominant Cannabis Flos Mitigates Severity of Post-Traumatic Stress Disorder Symptoms and Improves Quality of Sleep and General Mood in Cannabis-Experienced UK Civilians. Medical Cannabis and Cannabinoids, 2024;7(1):149–159. DOI: 10.1159/000540978.

This article is for general information only and is not medical advice. PTSD is a serious condition — please consult a qualified healthcare professional before making any treatment decisions, and do not stop prescribed treatment without medical guidance.